Seizure-treating device allows for targeted brain delivery; Phosphagenics expands to animal market;

> Scientists are working on a closed-loop implantable device to treat seizures, detecting brain patterns and delivering drugs as needed without external controls. Report

> Australian drug delivery firm Phosphagenics is expanding into the animal market, partnering with Equine Nutrition Australia to develop compounds for racehorses. News

> Researchers have discovered that porous nanosilica provide an ideal platform for delivering anti-inflammatory treatments to the throat, tonsils and sinuses. More

> Scientists at the University of Texas at San Antonio have received $200,000 in seed funding to expand their light-activated nanoparticle technology. Item

Suggested Articles

Takeda forged a feasibility pact to see whether it could pair a plasma-based therapy with Elektrofi's microparticle delivery tech.

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.